Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo
about
Studies of retroviral infection in humanized miceRole of human immunodeficiency virus type 1 integrase in uncoating of the viral core.Short communication: Activating stimuli enhance immunotoxin-mediated killing of HIV-infected macrophages.The HIV-1 central polypurine tract functions as a second line of defense against APOBEC3G/F.Residual HIV-1 DNA Flap-independent nuclear import of cPPT/CTS double mutant viruses does not support spreading infectionDisruption of Type I Interferon Induction by HIV Infection of T Cells.Human immunodeficiency virus reverse transcriptase: 25 years of research, drug discovery, and promise.Nucleocapsid protein function in early infection processes.Quantitative analysis of the time-course of viral DNA forms during the HIV-1 life cycleThe HIV-1 passage from cytoplasm to nucleus: the process involving a complex exchange between the components of HIV-1 and cellular machinery to access nucleus and successful integration.The importance of becoming double-stranded: Innate immunity and the kinetic model of HIV-1 central plus strand synthesis.Viral and cellular requirements for the nuclear entry of retroviral preintegration nucleoprotein complexes.HIV latency is influenced by regions of the viral genome outside of the long terminal repeats and regulatory genes.Mechanistic interplay among the M184I HIV-1 reverse transcriptase mutant, the central polypurine tract, cellular dNTP concentrations and drug sensitivity.Analysis of the viral elements required in the nuclear import of HIV-1 DNA.Establishment and maintenance of HIV latency: model systems and opportunities for intervention.HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome.HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore.Single mutations in HIV integrase confer high-level resistance to raltegravir in primary human macrophages.
P2860
Q26849806-1DCEA769-CDB6-4DC6-BAA5-461B8AC4F78DQ33826918-700C961B-0F1C-447F-BBD4-ADFFF1F0DABBQ34085094-7DF3CF62-7F41-4B17-83B7-D3F09864BDEBQ34296121-3B47FAAF-ADED-4A3F-B085-A23D2265D67CQ35582736-09A419C7-C44C-44EB-8CDF-59A93E72B5DCQ35777137-FD708EF9-C9F7-4F11-A6AC-4C62BDEAC077Q36435971-9A466099-025B-4806-A7B5-AB578A91E25CQ37086413-BF2417DF-2891-4F4C-8363-4D3B4CEF9D85Q37153500-D40B04E4-433F-4845-94BF-FEDAC947CF68Q38003158-168F0D33-0298-49E3-B380-D52DA9D6EC55Q38096531-4D641360-B21A-4AC6-97CA-6203850E1B7DQ38150610-0B34ECBF-18F5-4D6A-9E8E-35B18EC272D2Q38270498-7F51175D-9233-464C-A528-7E07F2502677Q39668635-5FB0D901-F202-4279-A935-356FCB449DFFQ39778927-94DCC5CD-7A00-4F93-ABDF-813FC84211A7Q39783316-BAE59860-0383-442A-819F-E0CF0328C76EQ39887537-63F24652-337A-409E-89C6-25E8F175B9BAQ41914326-A406F5B1-8D62-422B-9098-D5EF63940A73Q42849831-308107D6-3321-4F4A-9CAE-BB020BF0D82A
P2860
Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo
@ast
Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo
@en
type
label
Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo
@ast
Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo
@en
prefLabel
Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo
@ast
Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo
@en
P2860
P356
P1433
P1476
Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo
@en
P2093
Jerome A Zack
Matthew D Marsden
P2860
P304
P356
10.1128/JVI.00203-07
P407
P577
2007-03-28T00:00:00Z